This federal contract award, valued at $12,285.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes.
The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of December 4, 2024. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Generated 3/9/25, 1:01 AM